Trust CO Of Kansas Bristol Myers Squibb CO Transaction History

Trust CO Of Kansas

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $277,771 - $305,923	-3,825 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$61.48 - $73.72 $3,258 - $3,907	-53 Reduced 1.37%	3,825 $279,000
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $17,429 - $20,319	-325 Reduced 7.73%	3,878 $242,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $20,120 - $21,911	325 Added 8.38%	4,203 $281,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $230,120 - $258,817	3,878 New	3,878 $245,000

Q2 2020 Aug 17, 2020	SELL	$54.82 - $64.09 $216,155 - $252,706	-3,943 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $26,912 - $39,109	-580 Reduced 12.82%	3,943 $220,000
Q4 2019 Feb 20, 2020	BUY	$49.21 - $64.19 $222,576 - $290,331	4,523 New	4,523 $290,000

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85.2B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Trust CO Of Kansas, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Kansas with notifications on news.